Skip to content
healthcare.dev
Get a free key

Neostigmine Methylsulfate

NDC 70594-069, Neostigmine Methylsulfate, injection, from Xellia Pharmaceuticals USA LLC.

Product NDC
70594-069
Status
Listed
Labeler
Xellia Pharmaceuticals USA LLC
Dosage form
INJECTION
Route
INTRAVENOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213074
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70594-069 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • NEOSTIGMINE METHYLSULFATE.5 mg/mL

Pharmacologic classes

Cholinesterase Inhibitor [EPC]; Cholinesterase Inhibitors [MoA]

Package NDCNDC-11Package
70594-069-027059400690210 VIAL in 1 CARTON (70594-069-02) / 10 mL in 1 VIAL (70594-069-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/398d8193-e1e8-42b5-a95a-86cde967c7d0

Use it

Look up 70594-069 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70594-069 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70594-069. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.